STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES

Company

Vir Biotechnology, Inc.

Filed

June 24, 2021

Period of Report

June 22, 2021

Accession Number

0001062993-21-005942